Fear of Needles

Why needle fear makes the body drop

Most phobias produce the same cardiovascular signature. The feared thing appears, the pulse climbs, and it stays up until the threat is gone. Needle fear of the vasovagal kind does that for a moment and then reverses. Heart rate and blood pressure rise briefly, then both fall away, sometimes far enough to take consciousness with them, occasionally with convulsions and with rapid swings across a range of hormones. Pallor, sweating, dizziness, nausea and tinnitus travel with the drop. Fainting, not flight, is the outcome the type is named for.

An odd consequence follows. A good number of people who lose consciousness during injections say they have no conscious fear of the injection at all, and a considerable fear of the faint. What they avoid is the loss of blood pressure rather than the instrument that provokes it. The article goes further, citing a paper in Circulation which argued that in many patients a first fainting episode during a needle procedure is what produces the phobia, rather than an existing fear of needles producing the faint. The journal is named. The authors and the year are not.

Hamilton argued that the inherited form has a history several thousand years deep, on the reasoning that people who took unusual care to avoid puncture wounds had a better chance of surviving to have children. A second evolutionary account sits beside it and attaches to nobody at all. It proposes that fainting began as a signal rather than a failure, a way for a non-combatant to advertise harmlessness during the raised inter-group violence of the Paleolithic, which would explain why blood and injury in particular set it off. No name, no date and no paper accompanies that one.

Why trypanophobia never appears in its own article

Wikipedia files the subject under Fear of needles and tells its reader that the medical literature calls it needle phobia. Trypanophobia, the Greek form every phobia list leads with, exists on the encyclopedia only as a redirect, and the word does not occur once in the article it points to. Nothing there gives its roots, its coiner or its earliest use, so an entry written from that article can say what the fear is and cannot say where its formal name came from.

The alternative name is offered and withdrawn inside a single sentence. Aichmophobia is occasionally used for this fear, the article says, and may instead denote a general fear of anything sharply pointed, which leaves it a synonym some of the time and a wider term the rest of it.

Why the needle fear subtypes do not add up

The article divides needle fear four ways and puts a share on each:

1. vasovagal, half of all cases, and an inherited reflex rather than a learnt association
2. associative, thirty per cent, the ordinary conditioned phobia
3. resistive, twenty per cent, where the fear is of being held down
4. hyperalgesic, ten per cent, a fear of the pain and not of the instrument

The vasovagal type comes with about eighty per cent of people who fear needles reporting the same reaction in a parent, sibling or child. Sight, touch and the thought of a needle will each serve to trigger it.

The associative type is the conditioned one: a painful procedure, or the sight of one happening to a relative or a friend, after which everything involving a needle inherits the memory. Its symptoms are psychological rather than circulatory, running to anxiety with no clear object, insomnia, and a preoccupation with the appointment that grows as the date approaches.

The resistive type is not really about needles. The article traces it to repressive upbringing or to having been physically or emotionally restrained for an earlier procedure. It presents as combativeness and flight, and it drives blood pressure very high rather than letting it fall.

The hyperalgesic type is a fear of the pain. Here the article describes an inherited hypersensitivity that makes an injection unbearable and leaves the patient unable to understand how anybody tolerates one.

Those four shares total a hundred and ten per cent, and not one of them carries a citation. The arithmetic is worth noticing past the pedantry, because the four kinds do not behave alike. Two of them push blood pressure up and one of them pulls it down, so the familiar description of needle fear as the phobia that makes people faint holds for at most half the people being described.

Where the needle fear prevalence figures come from

At least a tenth of American adults have some degree of needle fear, on the article's account, and the true share is probably higher, since the most severe cases avoid medical care entirely and so never enter a record that could count them. No survey is named. Held to the stricter diagnostic threshold for the blood-injection-injury group, and counting blood-related fears alongside needle-related ones, the figure drops to three or four per cent of the general population. No survey is named for that one either.

The one trend the article reports is steep. Among children, needle fear is said to have risen from a quarter in 1995 to about two thirds by 2012, the later figure covering those born after 1999. Two studies are credited with showing it and neither is identified. Amy Baxter, a professor at Augusta University, is the single named person in the passage. Baxter argued that the rise follows the spread of booster shots given at around five years old, an age late enough for the child to remember the injection and early enough for the memory to harden into a phobia.

What the article does not carry anywhere is a distribution of ages at onset, a breakdown by sex, or a comparison between countries.

What sets needle fear off without a needle

Needle fear does not need a needle present. The article lists as triggers:

• blood, injuries and syringes
• drawing pins and anything sharply pointed
• examination rooms, dentists, nurses and white coats
• the antiseptic smell of a hospital corridor
• a needle on a screen
• a stranger who happens to resemble the patient's own doctor
• reading about the fear

That last item is a fair warning about pages of this kind, and about this one.

Watching is enough on its own. A person with the phobia can go through the full sequence, collapse included, while somebody else is being injected. Why is not established. The article observes that a pinprick felt and a pinprick watched activate the same region of the brain, calls its authority recent neuroscience research, and names no study.

Iatrophobia, fear of doctors, turns up alongside needle phobia often enough for the article to record the pairing. That matters beyond the curiosity, because avoiding doctors removes a person from the population any prevalence survey can reach.

Why relaxation is the wrong advice for needle fear

The standard preparation for a frightened patient is to help them relax, and here the article marks it as possibly contraindicated: relaxation lowers blood pressure, and lowered blood pressure is the event this phobia consists of. Graded exposure is paired instead with applied tension, in which the patient deliberately tightens muscle to hold pressure up, described as having gained acceptance more recently than desensitisation, which was the older approach. Tensing the abdominal muscles is given as the plain version of the same idea.

Most of what the article offers after that removes the pain or the awareness rather than the fear:

• freezing sprays and jet injectors that deliver a dose on compressed gas
• iontophoresis, driving anaesthetic through the skin on an electric current
• the creams EMLA and Ametop
• nitrous oxide and general anaesthesia by inhalation
• nasal delivery for the vaccines that permit it, the live attenuated influenza vaccine among them
• benzodiazepines, cited to Hamilton, taking effect five to fifteen minutes after a sufficiently large oral dose
• swearing, on the grounds that it reduces perceived pain

Several items on that list have nothing at all behind them. One has dates. A self-heating patch combining lidocaine and tetracaine, sold as Synera in the United States and Rapydan in the European Union, was cleared for needle procedures by the Food and Drug Administration on 23 June 2005 and took twenty to thirty minutes to reach full effect. On 11 November 2022 its manufacturer said it would stop making and selling it worldwide by the end of that year. The one product licensed for this exact problem is the one no longer on sale.

The article is candid about the state of the rest. Various treatments have worked in particular cases, it says, and the literature offers very little help in predicting which will work for which patient.